It has also been demonstrated that antiphospholipid antibodies, which are implicated in the pathogenesis of recurrent miscarriages, preeclampsia, and premature labour, increase the inflammatory capacity of first-trimester trophoblasts via the TLR4 pathway [41]. This evidence concerns the gene TLR4 and preeclampsia.